Archive for ADHD Medication Treatment

It has been known for a long time that ADD/ADHD runs in families. ADD/ADHD is very genetic. Heritability studies show that ADD/ADHD is about as genetic as height – i.e. it is in the 80-85% heritable.

A study was done that shows that it is quite common for more than one member of the family to be taking medication for ADD/ADHD.

Read More→

Technorati Tags: , , , ,

A study was recently published which demonstrated that Vyvanse (lisdexamfetamine dimesylate) works up to 14 hours in adults with ADD/ADHD.

In this study, measurements of adult ADD/ADHD symptom control were taken at 2 hours post medication, and were found to be effective all the way to 14 hours after the medication was taken.

Read More→

The news has been buzzing with the results of a new study which suggests that over 1 million American kids are misdiagnosed with ADHD, when they don’t in fact have it.

Read More→

Technorati Tags: , , , , ,

For many years – doctors suggested that people only take ADD/ADHD medication for school days. So, doctors suggested that people stop their stimulant medicine on weekends and holidays (including Christmas breaks, summer breaks, etc.).

Read More→

Technorati Tags: , , , ,

A recent new report shows that Watson Pharmaceuticals is cleared to create a generic form of Concerta for the US. A recent court of appeal decision is reported to have said that the patent on Concerta is invalid and that Watson is cleared to make their own version of the drug. Johnson and Johnson, the parent company which makes Concerta, had worldwide sales of $1.33 billion of Concerta last year.

Read More→

Technorati Tags: , , , , , ,

Comments (0)

Generic Intuniv?

Posted by: Dr. Kenny Handelman | Comments (1)

Although Intuniv is quite new, Shire Pharmaceuticals has had to continually fight to keep its patent protected for this new medicine.

Shire has had recent lawsuits against: Actavis and Teva. Now, they are fighting Anchen to protect their medicine.

Read More→

Technorati Tags: , ,

Comments (1)

A recent news release came out sharing that the global market for ADD/ADHD medications is expected to reach $4.2 Billion (with a ‘B)  worldwide by 2015. It is projected to go up to $3.3 Billion by 2012.

Read More→

Technorati Tags: , , , , , , , ,

Generic Concerta was introduced into Canada around February 2010. As I’ve written in my full article about Generic Concerta – I’m quite concerned about the fact that the new generic medicine does not have the same properties as brand name Concerta – and this may lead to problems for patients who are automatically switched from brand name Concerta to Novo-Methylphenidate ER C.

Read More→

Technorati Tags: , , , ,

Vyvanse is a prodrug stimulant medicine which was initially launched in the US for children (6-12 years old) with ADHD, and then later approved for adults (18-65 years old) with ADHD.

At the time of this post (late May 2010), Vyvanse is not officially indicated for teens (13 to 17 year olds) with ADHD.

Read More→

Technorati Tags:

Comments (1)

February 14, 2010

Vyvanse was launched in Canada officially on February 1st, 2010. Even though it was officially launched, there have been some issues with the ability of pharmacies to get Vyvanse on their shelves.

Read More→

Technorati Tags: , , , ,